The DOI matches its Crossref record.
Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
Abstract
Drugs derived from natural resources represent a significant segment of the pharmaceutical market as compared to randomly synthesized compounds. It is a goal of drug development programs to design selective ligands that act on single disease targets to obtain highly effective and safe drugs with low side effects. Although this strategy was successful for many new therapies, there is a marked decline in the number of new drugs introduced into clinical practice over the past decades. One reason for this failure may be due to the fact that the pathogenesis of many diseases is rather multi-factorial in nature and not due to a single cause. Phytotherapy, whose therapeutic efficacy is based on the combined action of a mixture of constituents, offers new treatment opportunities. Because of their biological defence function, plant secondary metabolites act by targeting and disrupting the cell membrane, by binding and inhibiting specific proteins or they adhere to or intercalate into RNA or DNA. Phytotherapeutics may exhibit pharmacological effects by the synergistic or antagonistic interaction of many phytochemicals. Mechanistic reasons for interactions are bioavailability, interference with cellular transport processes, activation of pro-drugs or deactivation of active compounds to inactive metabolites, action of synergistic partners at different points of the same signalling cascade (multi-target effects) or inhibition of binding to target proteins. “-Omics” technologies and systems biology may facilitate unravelling synergistic effects of herbal mixtures. Keywords: Phytotherapy, phytomedicine, phytochemicals, herbal medicinal products, natural products, synergy, antagonism, galanthamine, artemisinin, hormesis, Nrf2, CREB, UDP-glucuronyl transferases, sulfotransferases, Berberine, Berberis, HMP, molecules, Omics, Scutellaria baicalensis, Dioscorea sp, Hypericum perforatum, St. John's wort, Hyperforin, GABA, Ginkgo, Ginkgo biloba, Willow, Salix alba, Marihuana, Cannabis sativa, Licorice, Glycyrrhiza glabra, Ginger, Zingiber officinalis, Kava-Kava, Piper methysticum, Stinging Nettle, Urtica dioica, Sabal serrulata, Serenoa repens, Devil's Claw, Harpagophytum procumbens, Arnica, Arnica montana, metalloproteinase, (MMP)1, Flavonoids, Artemisia annua, Lycopene, Isoflavones, Polyphenols
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544
“…transport processes, (iii) activation of pro-drugs or deactivation of active compounds to inactive metabolites, (iv) action of synergistic partners at different points of the same signaling cascade (multi-target effects) or (v) inhibition of binding to target proteins (Efferth and Koch, 2011).”
BackgroundAlzohairy, M. A. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7382506 · Cited by 765
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
Efferth, T. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.009 · Cited by 632
Self-citationMolecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective
Saikia, S., & Bordoloi, M. (2019) · Current Drug Targets · doi:10.2174/1389450119666181022153016 · Cited by 571
Antibacterial mechanisms of cinnamon and its constituents: A review
Vasconcelos, N. G., Croda, J., & Simionatto, S. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.04.036 · Cited by 522
Metadata
- Authors
- Efferth, T., & Koch, E.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-01-01
- Volume
- 12
- Issue
- 1
- Pages
- 122-132
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W1970930356
- Cited by
- 560
- References
- 0
- FWCI
- 18.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy. https://app.cochat.ai/papers/10.2174/138945011793591626
- The paper
- Efferth, T., & Koch, E. (2011). Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy. Current Drug Targets. https://doi.org/10.2174/138945011793591626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.